Abschluss eines nicht-exklusiven Rabattvertrages gemäß§ 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu Bimzelx
The scope, dates and status of this tender. A free account opens every field.
Source: TED Europa
Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu Bimzelx (Wirkstoff: Bimekizumab, ATC-Code: L04AC21, Vertragslaufzeit: 01.10.2026-30.09.2028)
- Status
- Closed
- Sector
- Medical equipments, pharmaceuticals and personal care products
- Location
- Germany
- Updated
- 3 Nov 2026
- Source
- TED Europa
ConstructChat
Ask ConstructChat about Abschluss eines nicht-exklusiven Rabattvertrages gemäß§ 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu Bimzelx
Pick a question to edit it, or write your own.
First answer free · no account
Tender Information FAQ
Tender Information
Participants
| Not available for this record. |
Status
Original status | contract award notice |
Taiyo status | Closed |
Taiyo last update | 2026-11-03 |
Contact
| Not available for this record. |
Description
Description | Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu Bimzelx (Wirkstoff: Bimekizumab, ATC-Code: L04AC21, Vertragslaufzeit: 01.10.2026-30.09.2028) |
Original sector | Medical equipments, pharmaceuticals and personal care products |
Budget |
Location
Country | Germany |
Source
Source | TED Europa |
URL |
More Details
Record type | Tender |
Article published date | 2026-11-03 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this tender
- News and media coverage
- Technical research
Free account · no card · lands you back on this tender
